ORIOLA OYJ |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.913 EUR | +0.44% |
|
+1.88% | -15.17% |
| Jun. 06 | Oriola Oyj Announces Board Appointments | CI |
| Apr. 30 | Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 367.1 | 349.6 | 362.5 | 321.2 | 199.1 | 169.8 | - | - |
| Enterprise Value (EV) 1 | 486.7 | 476.6 | 463.3 | 297.5 | 178.5 | 151.7 | 152.7 | 169.8 |
| P/E ratio | 50.6 x | 31.7 x | 33.4 x | -174 x | -9.89 x | 90.9 x | 10.1 x | 7.58 x |
| Yield | 4.44% | 1.58% | 2% | 3.45% | 6.43% | 8.43% | 9.53% | 11% |
| Capitalization / Revenue | 0.21 x | 0.19 x | 0.19 x | 0.21 x | 0.13 x | 0.11 x | 0.11 x | 0.1 x |
| EV / Revenue | 0.28 x | 0.26 x | 0.25 x | 0.2 x | 0.12 x | 0.1 x | 0.09 x | 0.1 x |
| EV / EBITDA | 7.4 x | 7.61 x | 6.51 x | 6.48 x | 3.43 x | 4.66 x | 4.1 x | 4.27 x |
| EV / FCF | 7.77 x | 18.7 x | 26.9 x | 3.68 x | 29.7 x | 4.7 x | 11.4 x | 12.9 x |
| FCF Yield | 12.9% | 5.35% | 3.71% | 27.2% | 3.36% | 21.3% | 8.77% | 7.74% |
| Price to Book | 2.33 x | 2.02 x | 1.67 x | 1.4 x | 1.16 x | 1.03 x | 1.01 x | 0.96 x |
| Nbr of stocks (in thousands) | 181,401 | 181,313 | 181,348 | 181,377 | 181,399 | 181,411 | - | - |
| Reference price 2 | 2.025 | 1.902 | 2.005 | 1.740 | 1.088 | 0.9090 | 0.9090 | 0.9090 |
| Announcement Date | 2/7/20 | 2/18/21 | 2/18/22 | 2/16/23 | 2/16/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,721 | 1,801 | 1,882 | 1,516 | 1,494 | 1,557 | 1,615 | 1,678 |
| EBITDA 1 | 65.8 | 62.6 | 71.2 | 45.9 | 52.1 | 32.54 | 37.23 | 39.75 |
| EBIT 1 | 20.5 | 21 | 26.3 | 17.8 | 16.7 | 20.61 | 23.97 | 26.25 |
| Operating Margin | 1.19% | 1.17% | 1.4% | 1.17% | 1.12% | 1.32% | 1.48% | 1.56% |
| Earnings before Tax (EBT) 1 | 10.1 | 14.3 | 14.7 | 6.9 | -17.6 | 4.313 | 20.25 | 26.55 |
| Net income 1 | 8 | 11.3 | 11.3 | -2.4 | -20.7 | 1.922 | 16.13 | 22.2 |
| Net margin | 0.46% | 0.63% | 0.6% | -0.16% | -1.39% | 0.12% | 1% | 1.32% |
| EPS 2 | 0.0400 | 0.0600 | 0.0600 | -0.0100 | -0.1100 | 0.0100 | 0.0900 | 0.1200 |
| Free Cash Flow 1 | 62.6 | 25.5 | 17.2 | 80.9 | 6 | 32.25 | 13.4 | 13.15 |
| FCF margin | 3.64% | 1.42% | 0.91% | 5.34% | 0.4% | 2.07% | 0.83% | 0.78% |
| FCF Conversion (EBITDA) | 95.14% | 40.73% | 24.16% | 176.25% | 11.52% | 99.1% | 35.99% | 33.08% |
| FCF Conversion (Net income) | 782.5% | 225.66% | 152.21% | - | - | 1,678.05% | 83.06% | 59.24% |
| Dividend per Share 2 | 0.0900 | 0.0300 | 0.0400 | 0.0600 | 0.0700 | 0.0767 | 0.0867 | 0.1000 |
| Announcement Date | 2/7/20 | 2/18/21 | 2/18/22 | 2/16/23 | 2/16/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 499 | 372.7 | 394.6 | 480.9 | 374.2 | 354.7 | 383.6 | 352.6 | 386.6 | 375.1 | 403 | 374 | 400.5 |
| EBITDA 1 | 23 | 21.7 | 10.8 | 10.5 | 4.7 | 7.1 | 7 | 8.1 | 8.4 | 7 | 8.25 | 8.15 | 8.5 |
| EBIT 1 | 11.6 | 15 | 5.5 | 6.6 | 0.9 | 3.5 | 3.4 | 4.4 | 5.4 | 4 | 4.95 | 5.1 | 6.6 |
| Operating Margin | 2.32% | 4.02% | 1.39% | 1.37% | 0.24% | 0.99% | 0.89% | 1.25% | 1.4% | 1.07% | 1.23% | 1.36% | 1.65% |
| Earnings before Tax (EBT) 1 | 6.8 | 2.7 | 7.3 | 6.7 | -9.8 | 1.5 | 1.5 | -19.7 | -0.9 | -2 | 0.6 | 1.95 | 2.4 |
| Net income 1 | 5.3 | 8.8 | 12 | 14.6 | -37.9 | 1.1 | 1.2 | -20.2 | -2.8 | -2.3 | 0.2 | 1.35 | 1.35 |
| Net margin | 1.06% | 2.36% | 3.04% | 3.04% | -10.13% | 0.31% | 0.31% | -5.73% | -0.72% | -0.61% | 0.05% | 0.36% | 0.34% |
| EPS 2 | 0.0300 | 0.0500 | 0.0700 | 0.0800 | -0.2100 | 0.0100 | 0.0100 | -0.1100 | -0.0200 | -0.0100 | 0.005000 | 0.005000 | 0.0100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/18/22 | 4/28/22 | 7/22/22 | 10/27/22 | 2/16/23 | 4/27/23 | 7/21/23 | 10/31/23 | 2/16/24 | 4/25/24 | - | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 120 | 127 | 101 | - | - | - | - | - |
| Net Cash position 1 | - | - | - | 23.7 | 20.6 | 18.1 | 17.1 | - |
| Leverage (Debt/EBITDA) | 1.818 x | 2.029 x | 1.416 x | - | - | - | - | - |
| Free Cash Flow 1 | 62.6 | 25.5 | 17.2 | 80.9 | 6 | 32.3 | 13.4 | 13.2 |
| ROE (net income / shareholders' equity) | 7.82% | 6.9% | 5.9% | -1.1% | -10.4% | 1.14% | 9.98% | - |
| ROA (Net income/ Total Assets) | 1.34% | 1.08% | 1% | -0.23% | -2.18% | 0.28% | 1.85% | 2.47% |
| Assets 1 | 596.9 | 1,043 | 1,129 | 1,027 | 947.8 | 696.3 | 871.6 | 897.2 |
| Book Value Per Share 2 | 0.8700 | 0.9400 | 1.200 | 1.240 | 0.9400 | 0.8900 | 0.9000 | 0.9500 |
| Cash Flow per Share 2 | 0.4700 | 0.3200 | 0.2200 | 0.4300 | 0.0500 | 0.1500 | 0.1900 | - |
| Capex 1 | 21.8 | 32.8 | 22.8 | 8.5 | 3.6 | 16.8 | 20.2 | 27.4 |
| Capex / Sales | 1.27% | 1.82% | 1.21% | 0.56% | 0.24% | 1.08% | 1.25% | 1.63% |
| Announcement Date | 2/7/20 | 2/18/21 | 2/18/22 | 2/16/23 | 2/16/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.909
EUR
Average target price
1.05
EUR
Spread / Average Target
+15.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.17% | 184M | |
| +27.33% | 76.47B | |
| +13.87% | 8.65B | |
| -3.18% | 8.09B | |
| -36.08% | 6.38B | |
| +24.11% | 5.61B | |
| +2.82% | 4.15B | |
| -7.61% | 3.89B | |
| -11.12% | 3.26B | |
| +9.93% | 3.2B |
- Stock Market
- Equities
- OKDBV Stock
- Financials Oriola Oyj
